RNU7-29P

Across TCGA pan-cancer cohorts, RNU7-29P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU7-29P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RNU7-29P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-29P expression acts as an unfavorable survival marker, although some lineages such as LAML and STAD show a favorable association.

LUSC, GBM, and LAML are the cancer types where RNU7-29P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	All	0.501	0.762	<.001	66	view →
GBM	DFS	Tertile	All	0.043	0.257	<.001	36	view →
LAML	DFS	Tertile	All	0.821	0.354	.049	12	view →
STAD	OS	Tertile	II,III,IV	0.663	0.358	.040	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU7-29P–LUSC (OS)

Open the LUSC breakdown →